A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/165 (2006.01) A61K 31/196 (2006.01) A61P 27/02 (2006.01) A61P 27/06 (2006.01)
Patent
CA 2483275
The use of amfenac and derivatives, including nepafenac, to treat vascular endothelial growth factor mediated vascular disorders.
L'invention porte sur l'utilisation d'amfenac et de ses dérivés dont le népafénac, pour traiter les troubles vasculaires médiés par le facteur de croissance endothélial.
Bingaman David P.
Gamache Daniel A.
Graff Gustav
Kapin Michael A.
Yanni John M.
Alcon Inc.
Smart & Biggar
LandOfFree
Method of treating vascular endothelial growth factor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating vascular endothelial growth factor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating vascular endothelial growth factor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1919361